Ignite Creation Date:
2025-12-24 @ 11:49 PM
Ignite Modification Date:
2026-05-17 @ 5:57 PM
Study NCT ID:
NCT01514851
Status:
COMPLETED
Last Update Posted:
2012-06-08
First Post:
2012-01-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase III Double-blind Comparative Study of BAY77-1931 (Lanthanum Carbonate) With Calcium Carbonate
Sponsor:
Bayer
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
11877
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Head Medical Development Japan
Old Organization:
Bayer Yakuhin Ltd.